20-20495165-G-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_020343.4(RALGAPA2):c.5319C>T(p.Tyr1773Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 1,611,074 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0042 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0053 ( 37 hom. )
Consequence
RALGAPA2
NM_020343.4 synonymous
NM_020343.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.49
Genes affected
RALGAPA2 (HGNC:16207): (Ral GTPase activating protein catalytic subunit alpha 2) Predicted to enable GTPase activator activity and protein heterodimerization activity. Predicted to be involved in activation of GTPase activity. Predicted to act upstream of or within Ral protein signal transduction; regulation of exocyst localization; and regulation of protein localization. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 20-20495165-G-A is Benign according to our data. Variant chr20-20495165-G-A is described in ClinVar as [Benign]. Clinvar id is 789355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.49 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00526 (7680/1458790) while in subpopulation AMR AF= 0.0217 (968/44650). AF 95% confidence interval is 0.0205. There are 37 homozygotes in gnomad4_exome. There are 3748 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RALGAPA2 | ENST00000202677.12 | c.5319C>T | p.Tyr1773Tyr | synonymous_variant | Exon 36 of 40 | 5 | NM_020343.4 | ENSP00000202677.6 | ||
RALGAPA2 | ENST00000430436.5 | c.4767C>T | p.Tyr1589Tyr | synonymous_variant | Exon 30 of 33 | 5 | ENSP00000400085.1 | |||
RALGAPA2 | ENST00000427175.2 | c.549C>T | p.Tyr183Tyr | synonymous_variant | Exon 5 of 6 | 2 | ENSP00000388695.1 |
Frequencies
GnomAD3 genomes AF: 0.00423 AC: 644AN: 152166Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
644
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00734 AC: 1828AN: 248924Hom.: 14 AF XY: 0.00622 AC XY: 840AN XY: 135036
GnomAD3 exomes
AF:
AC:
1828
AN:
248924
Hom.:
AF XY:
AC XY:
840
AN XY:
135036
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00526 AC: 7680AN: 1458790Hom.: 37 Cov.: 30 AF XY: 0.00516 AC XY: 3748AN XY: 725708
GnomAD4 exome
AF:
AC:
7680
AN:
1458790
Hom.:
Cov.:
30
AF XY:
AC XY:
3748
AN XY:
725708
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00423 AC: 644AN: 152284Hom.: 2 Cov.: 33 AF XY: 0.00438 AC XY: 326AN XY: 74462
GnomAD4 genome
AF:
AC:
644
AN:
152284
Hom.:
Cov.:
33
AF XY:
AC XY:
326
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 11, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at